ARCHIVES

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

This article is from The Cancer Letter archive.

Vol. 27 No. 27 | July 6, 2001

Download PDF Visit The Full Archive

Related Articles

BMS Settles Charges Of Obstructing Generics

March 14, 2003

Over $20 Million Carved Out From Statistical, Operations Centers

May 16, 2014

Obey Attacks NCI In Campaign Speech

October 29, 1976

Hypothyroidism Associated With Reduced Breast Cancer

April 25, 2003

High Risk workshop Planned To Produce Monograph On Current Knowledge

October 11, 1974

M.D. Anderson Stops Establishing Satellite Clinics, Views Role as Working With All Texas Oncologists

November 22, 1996